We have isolated a cDNA from rat small intestine that encodes a novel Na ؉ -independent neutral amino acid transporter with distinctive characteristics in substrate selectivity and transport property. The encoded protein, designated L-type amino acid transporter-2 (LAT-2), shows amino acid sequence similarity to the system L Na ؉ -independent neutral amino acid transporter LAT-1 (Kanai, Y., Segawa, H., Miyamoto, K., Uchino, H., Takeda 
273, 32437-32445). LAT-2 is a nonglycosylated membrane protein. It requires 4F2 heavy chain, a type II membrane glycoprotein, for its functional expression in Xenopus oocytes. LAT-2-mediated transport is not dependent on Na
؉ or Cl ؊ and is inhibited by a system L-specific inhibitor, 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid (BCH), indicating that LAT-2 is a second isoform of the system L transporter. Compared with LAT-1, which prefers large neutral amino acids with branched or aromatic side chains, LAT-2 exhibits remarkably broad substrate selectivity. It transports all of the L-isomers of neutral ␣-amino acids. LAT-2 exhibits higher affinity (K m ‫؍‬ 30 -50 M) to Tyr, Phe, Trp, Thr, Asn, Ile, Cys, Ser, Leu, Val, and Gln and relatively lower affinity (K m ‫؍‬ 180 -300 M) to His, Ala, Met, and Gly. In addition, LAT-2 mediates facilitated diffusion of substrate amino acids, as distinct from LAT-1, which mediates amino acid exchange. LAT-2-mediated transport is increased by lowering the pH level, with peak activity at pH 6.25, because of the decrease in the K m value without changing the V max value. Because of these functional properties and a high level of expression of LAT-2 in the small intestine, kidney, placenta, and brain, it is suggested that the heterodimeric complex of LAT-2 and 4F2 heavy chain is involved in the trans-cellular transport of neutral amino acids in epithelia and blood-tissue barriers.
The transport of neutral amino acids through the plasma membrane is mediated via Na ϩ -dependent and Na ϩ -independent transport systems (1, 2) . Among them, the Na ϩ -dependent systems ASC and A and Na ϩ -independent system L are the major routes to provide cells with neutral amino acids. System ASC transports small neutral amino acids without bulky side chains such as alanine, serine, threonine, and cysteine (1). ASCT1 and ASCT2, which are structurally related to glutamate transporters, have been assigned to system ASC (3-6). System A transports neutral amino acids including proline and accepts N-methyl amino acids such as ␣-(aminomethyl)isobutyric acid (1) . The molecular nature of system A has not been determined yet. System L has been described originally as a transport agency responsible for the transport of large neutral amino acids with branched or aromatic side chains (1, 7, 8) . Various subtypes with different characteristics in substrate selectivity and transport property have, however, been described so far for system L (9 -14) . System L is essential not only in cellular nutrition but also in trans-cellular transport of neutral amino acids at epithelia and blood-tissue barriers (1, 14 -17) .
Recently, we have isolated a cDNA encoding a system L transporter, LAT-1, 1 by performing expression cloning in which the heavy chain of the 4F2 cell surface antigen (CD98) and rat C6 glioma cell cDNA library are co-expressed in Xenopus oocytes (18) . We have demonstrated that co-expression of LAT-1 and 4F2 heavy chain (4F2hc) results in the functional expression of system L activity. 4F2 antigen is a heterodimeric protein composed of two subunits, an ϳ80-kDa glycosylated heavy chain and an ϳ40-kDa nonglycosylated light chain (19, 20) . 4F2hc is an integral membrane protein with a single membrane-spanning domain classified as a type II membrane protein (21) . It has been shown that LAT-1 is one of the proteins formerly referred to as 4F2 light chain (22) (23) (24) . 4F2hc also associates with y ϩ LAT-1 and KIAA0245/y ϩ LAT-2 system y ϩ L transporters, which accept both neutral and basic amino acids (25, 26) .
When LAT-1 is co-expressed with 4F2hc in Xenopus oocytes, it induces the Na ϩ -independent and trans-stimulable transport * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.This work was supported in part by grants from the Ministry of Education, Science, Sports of large neutral amino acids such as leucine, isoleucine, valine, phenylalanine, tyrosine, tryptophan, methionine, and histidine, consistent with the property originally described by Christensen and co-workers (1, 18) for system L in Ehrlich ascites carcinoma cells. We expected that other unidentified subtypes of system L were structurally related to LAT-1. We searched for such proteins and identified a second isoform of system L transporter, which exhibits distinct characteristics in substrate selectivity and functional properties.
EXPERIMENTAL PROCEDURES
cDNA Cloning-The cDNA for a human expressed sequence tag (EST) (GenBank/EBI/DDBJ accession no. N32639), which we found in the course of EST data base searches to show nucleotide sequence similarity to rat LAT-1, was obtained from the Integrated and Molecular Analysis of Genomes and their Expression (IMAGE). The 0.38-kilobase pair cDNA fragment was amplified by polymerase chain reaction using synthetic oligonucleotide primers 5Ј-CTCTTCACATGCATC-TCCAC-3Ј and 5Ј-GGTACACGACCACACACATC-3Ј (corresponding to nucleotides 35-54 and 397-416, respectively, of the nucleotide sequence submitted to GenBank/EBI/DDBJ under accession no. N32639) and using the IMAGE cDNA clone 267666 as a template. The cDNA fragment was labeled with [ 32 P]dCTP ( T7 QuickPrime, Amersham Pharmacia Biotech) to use as a probe for screening a nondirectional cDNA library. The cDNA library was prepared from rat small intestine poly(A) ϩ RNA using the Superscript Choice system (Life Technologies, Inc.). The synthesized cDNA was ligated to ZipLox EcoRI arms (Life Technologies, Inc.). Screening cDNA library and isolation of positive plaques were performed as described elsewhere (5, 27) . Hybridization was done in 50% formamide at 37°C. Filters were washed at 37°C in 0.1ϫ SSC (1ϫ SSC ϭ 0.15 M sodium chloride, 0.015 M sodium citrate, pH 7.0), 0.1% sodium dodecyl sulfate. cDNAs in positive ZipLox phages were rescued into plasmid pZL1 by in vivo excision following the manufacturer's instruction (Life Technologies, Inc.). The cDNA was sequenced in both directions by the dye terminator cycle sequencing method (Perkin-Elmer and Applied Biosystems). The transmembrane regions of proteins were predicted on the amino acid sequence based on the SOSUI algorithm (28) . In vitro translation of cRNA was performed as described elsewhere (18, 29, 30) .
Xenopus Oocyte Expression-cRNAs were obtained by in vitro transcription using T7 RNA polymerase for LAT-2 in plasmid pZL1, linearized with HindIII, and for rat 4F2hc in pBluescript II SK, linearized with XbaI as described elsewhere (31) . Xenopus oocyte expression studies and uptake measurements were performed as described (5, 32) . The uptake rates of 14 C-labeled amino acids were measured 3 days after injection of cRNA. For co-expression experiments, 17 ng of LAT-2 cRNA and 8 ng of 4F2hc cRNA (mole ratio of 1:1) were mixed and injected for each oocyte. To solely express LAT-2 and 4F2hc in Xenopus oocytes, 17 and 8 ng of cRNAs were injected for LAT-2 and 4F2hc, respectively. The Xenopus oocyte expression of LAT-1 and 4F2hc was performed as described (18) .
Amino Acid Uptake Measurements-Groups of six to eight oocytes were incubated in 500 l of standard uptake solution (100 mM NaCl, 2 mM KCl, 1 mM CaCl 2 , 1 mM MgCl 2 , 10 mM HEPES, and 5 mM Tris, pH 7.4) or Na ϩ -free uptake solution in which NaCl in the standard uptake solution was replaced by choline chloride containing 0.5-3.0 Ci of radiolabeled compounds (5) . To prepare uptake solution with varied pH for pH dependence experiments, MES-NaOH (pH 5.5, 5.75, 6.0, and 6.25), PIPES-NaOH (pH 6.5 and 7.0), HEPES-NaOH (pH 7.5 and 8.0), and Tris-HCl (pH 8.5) were used for buffer systems (5) . Preliminary experiments to determine the time course of L-[ 14 C]leucine (100 M) uptake into oocytes expressing LAT-2 and 4F2hc indicated that the uptake was linearly dependent on incubation time up to 20 min (data not shown), so for all of the following experiments uptakes were measured for 15 min and the values were expressed as pmol/oocyte/min.
The K m and V max of amino acid substrates were determined using the Eadie-Hofstee equation based on the LAT-2-mediated amino acid uptakes measured at 3, 10, 30, 100, 300, 1000, and 3000 M. The LAT-2-mediated amino acid uptakes were calculated as the differences between the means of uptakes of the oocytes injected with cRNAs and those of the control oocytes injected with water.
Efflux Measurements-For the efflux measurements, 14 C-labeled Lleucine and other amino acids were preloaded by incubating the oocytes expressing LAT-2 and 4F2hc or LAT-1 and 4F2hc in the Na ϩ -free uptake solution containing 150 (for LAT-2) or 20
14 C]leucine for 30 min. Then, the individual oocytes were washed five times with ice-cold Na ϩ -free uptake solution and transferred to Na ϩ -free uptake solution with or without nonradiolabeled L-leucine (18, 33) . The radioactivity in the medium and the remaining radioactivity in the oocytes were measured. The values were expressed as: % radioactivity (radioactivity of medium or oocytes/(radio activity of medium ϩ radio activity of oocytes) ϫ 100%).
Radiolabeled amino acids used were the following: U- For the measurements of the uptake and the efflux of radiolabeled amino acids in the present study, six to eight oocytes were used for each data point. Each data point in the figures represents the mean Ϯ S.E. of uptake or efflux values (n ϭ 6 -8). To confirm the reproducibility of the results, three separate experiments were performed for each measurement using different batches of oocytes and in vitro transcribed cRNA, except for K m and V max determination (see Table I ). Results from the representative experiments are shown in the figures.
Northern Analysis-Poly(A) ϩ RNA (3 g/lane) isolated from rat tissues and rat C6 glioma cells was separated on a 1% agarose gel in the presence of 2.2 M formaldehyde and blotted onto a nitrocellulose filter (Schleicher & Schuell) as described (5, 34) . The HincII fragment of LAT-2 cDNA, corresponding to 1126 -1591 base pairs, and the polymerase chain reaction-amplified fragment of 4F2hc cDNA, corresponding to 211-656 base pairs (GenBank/EBI/DDBJ accession no. AB015433), were labeled with 32 P using the T7 QuickPrime kit (Amersham Pharmacia Biotech). Hybridization was for 20 h at 42°C in 50% formamide. The final stringent wash of the filter was in 0.1ϫ SSC, 0.1% sodium dodecyl sulfate at 65°C for 3 ϫ 20 min (5, 34). C6 glioma cells were provided by the Health Science Research Resources Bank, Japan Health Sciences Foundation.
RESULTS

Structural Features of LAT-2-
A cDNA clone with a 4117-base pair insert was isolated from a rat small intestine cDNA library. It contained an open reading frame from nucleotides 601 to 2199 encoding a 533-amino acid protein designated LAT-2 (L-type amino acid transporter-2). The start of the coding sequence was defined by the first ATG downstream of the in-frame stop codon and by the surrounding sequences (AA-GATGG) corresponding to the KozaK consensus translation initiation sequence (35) . The cDNA includes the poly(A) tail (17 As), which starts 22 nucleotide downstream from a typical polyadenylation signal AATAAA at nucleotide 4079.
The LAT-2 amino acid sequence exhibited remarkable homology to those of rat system L transporter LAT-1 (50% identity) (18) and human y ϩ L transporters y ϩ LAT-1 (47%) (25) and KIAA0245/y ϩ LAT-2 (45%) (25, 36) (Fig. 1) . LAT-2 also exhibited significant homology to system y ϩ transporters CAT1ϳ4 (30 -31%) from mice and humans (2) and amino acid permeases from bacteria and yeasts (e.g. 31% identity to Saccharomyces cerevisiae methionine permease MUP1 (37)).
As shown in Fig. 1 , 12 transmembrane regions were predicted on the LAT-2 amino acid sequence. There is a conserved cysteine residue (LAT-2 amino acid residue 155) in the putative extracellular loop between predicted transmembrane domains 3 and 4, which is supposed to link to 4F2hc via a disulfide bond (38) . A tyrosine kinase-dependent phosphorylation site was predicted at residue 110 in the putative intracellular loop between predicted transmembrane domains 2 and 3, which is conserved for system L transporter LAT-1 but not for system y ϩ L transporters y ϩ LAT-1 and KIAA0245/y ϩ LAT-2 ( Fig. 1) . Protein kinase C-dependent phosphorylation sites were predicted in the putative intracellular loops (see legend for Fig. 1 ), among which one at residue 338 is conserved for LAT-1 and KIAA0245/y ϩ LAT-2 but not for y ϩ LAT-1. In vitro translation of LAT-2 showed a band of 49-kDa protein (Fig. 2) . LAT-2 was not glycosylated by canine pancreatic microsomes (Fig. 2) . The functional properties of LAT-2 were examined by coexpression with 4F2hc in Xenopus oocytes. The L-[ 14 C]leucine uptake was not dependent on Na ϩ or Cl Ϫ (Fig. 3b) . The uptake was saturable and followed Michaelis-Menten kinetics with a K m value of 119.7 Ϯ 33.6 M (mean Ϯ S.E. of 4 separate experiments) for L-[
14 C]leucine (Fig. 4) . Substrate selectivity of LAT-2 was investigated by inhibition experiments in which 50 M L-[ 14 C]leucine uptake was measured in the presence of 5 mM nonlabeled amino acids. As shown in Fig. 5a , the leucine uptake was inhibited by glycine and L-isomers of the neutral amino acids and histidine. Proline, cystine, the acidic amino acids glutamate and aspartate and basic amino acids lysine and arginine did not inhibit LAT-2-mediated L-[
14 C]leucine uptake (Fig. 5a ). ␤-amino acid ␤-alanine, taurine, and ␥-amino acid ␥-aminobutyric acid affected LAT-2-mediated transport less (data not shown). D-serine, Dasparagine, and some other D-amino acids exhibited weak inhibitory effects on LAT-2-mediated transport (Fig. 5b) . The leucine uptake was inhibited by system L-specific inhibitor 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid (BCH) (39), whereas it was not inhibited by ␣-(aminomethyl)isobutyric acid or ␣-aminoisobutyric acid. The uptake rates of 100 M radiolabeled amino acids were measured. As shown in Fig. 6 , LAT-2 transported glycine and L-isomers of neutral amino acids, including small amino acids such as alanine, serine, threonine, and cysteine, and large Residues that are identical between at least two sequences are shaded. Predicted transmembrane regions of LAT-2 numbered 1-12 are shown by lines above the sequences. In LAT-2, a potential tyrosine kinase-dependent phosphorylation site is located at residue 110 (indicated by #). Protein kinase C-dependent phosphorylation sites are predicted on the LAT-2 sequence at residues 11, 62, 180, 338, and 488, among which the sites at residues 11, 338, and 488 are predicted to be located intracellularly (indicated by *). A potential cAMP-dependent phosphorylation site is located at residue 364. Residue numbers indicated above the aligned sequences refer to the amino acid sequence of LAT-2. 14 C]leucine measured in the Na ϩ uptake solution (Na) was not altered in the uptake medium in which Na ϩ was replaced by choline ϩ (Choline) or Cl Ϫ was replaced by gluconate Ϫ (gluconate).
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amino acids with branched or aromatic side chains. LAT-2 did not transport the acidic amino acids, basic amino acids, and D-amino acids tested (Fig. 6 ). As shown in Table I , LAT-2 exhibits higher affinity (K m ϭ 30 -150 M) to tyrosine, phenylalanine, tryptophan, threonine, asparagine, isoleucine, cysteine, serine, leucine, valine, and glutamine and relatively lower affinity (K m ϭ 180 -300 M) to histidine, alanine, methionine, and glycine.
pH Dependence of Transport-The effect of pH on LAT-2-mediated L-[
14 C]leucine transport was examined by changing the pH of the uptake solution. As shown in Fig. 7a 14 C]leucine transport was altered by changing the pH of the uptake solution, whereas the V max value was less affected (K m ϭ 96.6 M, V max ϭ 6.7 pmol/oocyte/min at pH 7.5; K m ϭ 57.2 M, V max ϭ 7.0 pmol/oocyte/min at pH 6.25; determined on the same batch of oocytes) (Fig. 7b) . (Fig. 8b) . L-leucine applied extracellularly greatly enhanced the LAT-1-mediated L-[
Amino Acid Efflux Mediated via LAT-2-The
14 C]leucine efflux. The efflux experiments were further conducted on various radiolabeled substrates. An efflux of alanine, serine, threonine, cysteine, asparagine, glutamine, isoleucine, valine, methionine, phenylalanine, tyrosine, tryptophan, and histidine, as well as leucine, was detected (8 -25% of preloaded radioactivity for 5 min; data not shown).
Tissue Distribution of Expression-The expression of LAT-2 mRNA was analyzed by Northern blotting of poly(A) ϩ RNAs from various rat tissues. A 4.4-kilobase pair message was expressed in the jejunum, ileum, kidney, placenta, brain, testis, and skeletal muscle (Fig. 9a) . In contrast, the 4F2hc signal was detected ubiquitously. The kidney, jejunum, ileum, colon, placenta, and spleen showed relatively higher expression levels of 4F2hc mRNA (Fig. 9b) . DISCUSSION In the present study, we have identified a novel protein (LAT-2) that is structurally related to the formerly identified system L amino acid transporter LAT-1 (18) and system y ϩ L transporters y ϩ LAT-1 and KIAA0245/y ϩ LAT-2 (25, 26) . LAT-2 transports neutral amino acids in a Na ϩ -independent manner and is sensitive to a system L-specific inhibitor, BCH. LAT-2, therefore, corresponds to amino acid transport system L (1). LAT-2, as well as LAT-1, y ϩ LAT-1, and KIAA0245/y ϩ LAT-2, requires 4F2hc for its functional expression (Fig. 3) . We propose, therefore, a family of amino acid transporters associated with 4F2hc that is composed of structurally related transporters and includes transporters for system L and system y ϩ L and possibly still unidentified transporters with varied properties: the "LAT family," named after the first member LAT-1.
In vitro translation of LAT-2 cRNA shows that LAT-2 is a 49-kDa protein that is not glycosylated by canine pancreatic microsomes (Fig. 2) . This finding is in agreement with the observation that LAT-1 is not glycosylated, while 4F2hc is glycosylated (18) . 4F2 antigen has been shown to be a heterodimeric protein composed of an ϳ80-kDa glycosylated heavy chain and an ϳ40-kDa nonglycosylated light chain (19, 20) . LAT-2 is proposed to be linked to 4F2hc in tissues that express LAT-2 messages and should be regarded as a 4F2 light chain in such tissues.
LAT-2 exhibits remarkably broad substrate selectivity. It transports glycine and all of the L-isomers of neutral ␣-amino acids including small amino acids without bulky side chains and large amino acids with branched or aromatic side chains (Fig. 6) . Although the affinity of LAT-2 to substrate amino acids is lower than that of LAT-1 (K m for L-leucine is 18 M in LAT-1 (18)), LAT-2 still exhibits high affinity to all of the neutral amino acids (K m values for substrate amino acids are between 30 and 300 M; see Table I ). LAT-1, in contrast, prefers large neutral amino acids with branched or aromatic side chains (18) . System y ϩ L transporters y ϩ LAT-1 and KIAA0245/ y ϩ LAT-2 transport both neutral and basic amino acids; however, their substrate selectivity to neutral amino acids is relatively narrow (25, 26) . In insects, the K ϩ -dependent transporter KAAT1, structurally related to mammalian Na ϩ -and Cl Ϫ -dependent neurotransmitter transporters, has been identified and exhibits broad substrate selectivity to neutral amino acids (40) . Although a significant similarity has not been detected between LAT-2 and KAAT1 amino acid sequences, it is interesting to know what structural traits are responsible for such similar broad substrate selectivity developed among different transporter families.
It has been reported that amino acid transport system L is modulated by protein kinase C-dependent phosphorylation (1, 41, 42) . Protein kinase C-dependent phosphorylation sites are predicted on the LAT-2 amino acid sequence. Some of them are located in the predicted intracellular loops. Of particular interest among them is Ser-338, which is conserved among LAT-2, LAT-1, and KIAA0245/y ϩ LAT-2. In addition, it is notable that there is a putative tyrosine phosphorylation site that is conserved between LAT-2 and LAT-1 (Fig. 1) . Although the regulation by tyrosine phosphorylation has not been demonstrated for system L, there is an interesting observation that the monoclonal antibody against 4F2hc causes the tyrosine kinase-dependent phosphorylation of ϳ125 kDa protein (43) . It would be interesting to know whether the phosphorylated protein is a heterodimeric complex of the heavy chain and the light chain of 4F2 antigen, because the size of the phosphorylated protein corresponds well with that of the 4F2 heterodimeric complex (19, 20, 43) .
LAT-2-mediated L-leucine transport is accelerated by lower- FIG. 4 . Concentration dependence of LAT-2-mediated L-leucine uptake. The LAT-2-mediated L-leucine uptake was measured at 3, 10, 30, 100, 300, 1000, and 3000 M in Na ϩ -free uptake solution on oocytes co-expressed with LAT-2 and 4F2hc and plotted against L-leucine concentration. The leucine uptake was saturable and was fitted to the Michaelis-Menten curve. Inset, Eadie-Hofstee plot of the L-leucine uptake on which kinetic parameters were determined.
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ing the pH, giving a peak uptake value at pH 6.25 ( Fig. 7a) , whereas LAT-1-mediated transport is reported not to be influenced by pH level (44) . This stimulation of uptake is due to the increase in the affinity without changing the V max (Fig. 7b) . Such a pH-dependent property is consistent with that reported for mammalian system L in various cell types and tissues (1, 45) . In Chang liver cells, it was shown that leucine uptake via system L is accompanied by intracellular acidification, suggesting H ϩ co-transport for system L (45), although the role of H ϩ in system L has not been determined at the moment.
In the experiment in which we measured the efflux of preloaded L-[ 14 C]leucine, LAT-2 exhibited totally different properties than LAT-1. The level of the efflux mediated via LAT-1 is fairly low, whereas it is highly stimulated by the extracellularly applied L-leucine, reflecting the amino acid exchange via LAT-1 (Fig. 8b) . In contrast, the efflux of preloaded L-[ 14 C]leucine was detected even in the absence of extracellular L-leucine (Fig. 8a) . Additionally, extracellularly applied L-leucine did not enhance the LAT-2-mediated efflux, which suggests that LAT-2-mediated transport is the result of the facilitated diffusion rather than the obligatory exchange. LAT-2, thus, denotes a facilitated type of system L transporter, whereas LAT-1 is an exchanger type.
There have been some reports indicating heterogeneity in 
Na
ϩ -independent Broad Scope Neutral Amino Acid Transporterthe properties of system L regarding substrate selectivity, affinity, and whether it is trans-stimulable or not (9 -14) . In the trout, system L in red blood cells is high affinity, trans-stimulable, and not stereospecific in leucine uptake, whereas in peripheral lymphocytes it is low affinity, trans-inhibitable and stereospecific (9) . In primary hepatocyte culture, it was shown that system L, with low affinity and narrow substrate selectivity, is predominant in freshly isolated hepatocytes, but it is replaced by the other subtype of system L with high affinity and broader substrate selectivity over the initial 24 -48 h of ϩ RNA (3 g) from rat tissues. A single hybridizing band at 4.4 kilobase pairs was detected in the brain, skeletal muscle, kidney, jejunum, ileum, testis, and placenta. b, 4F2hc. The 4F2hc signal was detected ubiquitously. The kidney, jejunum, ileum, colon, placenta, and spleen showed relatively higher expressions of 4F2hc mRNA. b K m for L-leucine is the mean of four measurements (mean Ϯ S.E. ϭ 119.7 Ϯ 33.6 M).
FIG. 7.
The effects of pH on the LAT-2-mediated transport. a, the uptake of L-[ 14 C]leucine (100 M) was measured in the Na ϩ -free uptake solution with varied pH. The uptake value was greatest at pH 6.25. The asterisk above each data point indicates the statistical significance compared with the uptake value at pH 6.25 (p Ͻ 0.05, Student's unpaired t test). b, the concentration dependence of L-leucine uptake was determined in the Na ϩ -free uptake solution at pH 7.5 (filled circles) and at pH 6.25 (filled triangles). The concentration dependence profile for leucine transport was shifted by changing pH. The values were fitted to the Michaelis-Menten curve.
Na
ϩ -independent Broad Scope Neutral Amino Acid Transporterculture (10) . The functional properties of LAT-1 are similar to those of the system L in trout red blood cells and of the system L that appears in the adaptation of hepatocytes to tissue culture conditions. In the membrane vesicle preparation from epithelial tissues, system L activity has been described as exhibiting broader substrate selectivity, accepting not only large neutral amino acids but also small neutral amino acids, which distinguishes it from the system L found in Ehrlich ascites carcinoma cells that accepts mainly large neutral amino acids (1, 13, 14) . The functional properties of LAT-2 are similar to those of the system L found in epithelial tissues. mRNA expression of LAT-2 was detected in the small intestine, kidney, placenta, brain, testis, and skeletal muscle (Fig.  9a) . In the small intestine and renal proximal tubules, neutral amino acids absorbed from the luminal fluid via Na ϩ -dependent system B 0 , situated on the apical membrane of the epithelial cells, pass through the basolateral membrane via system L with broad substrate selectivity (1, 13, 14) . Based on the present investigation, it is proposed that LAT-2 could fulfill the task once it exists on the basolateral membrane of epithelial cells. As described under "Result," intracellularly loaded neutral amino acids, in fact, efficiently move out of the cells via LAT-2 by the facilitated diffusion mechanism. In blood-tissue barriers such as the blood-brain barrier and the placenta barrier, the permeation of neutral amino acids has been proposed to be mediated via system L (15) (16) (17) . High level expression of the LAT-2 message in those tissues suggests the involvement of LAT-2 in the proposed trans-cellular transport of neutral amino acids.
As Fig. 9b shows, 4F2hc mRNA is expressed ubiquitously. As well as LAT-2, the expression of LAT-1 and y ϩ LAT-1 is also restricted to certain tissues (18, 25, 26) . The expression of KIAA0245/y ϩ LAT-2 is reported to be relatively ubiquitous (36) . All of these transporters, however, are still unable to explain the ubiquitous expression of 4F2hc. In particular, no transporters have been identified in liver as associating with 4F2hc, although in vitro and in vivo experiments have demonstrated that hepatocytes possess strong system L activity (1, 10, 18) . Therefore, still unidentified transporters that belong to the LAT family and associate with 4F2hc are expected to exist, so that the family will be expanded more to include multiple transporters with various properties.
